Takeda Completes Acquisition of Nimbus Therapeutics' TYK2 Pr

OSAKA, Japan & CAMBRIDGE, Mass.--(BUSINESS WIRE)--Takeda (TSE:4502/NYSE:TAK) today announced that it has completed an acquisition of all shares of Nimbus La

Related Keywords

Japan , Osaka , United States , Ramona Sequeira , Megan Ostrower , Christopher Oreilly , Nimbus Lakshmi Inc , Exchange Commission , Nimbus Therapeutics , Takeda Pharmaceutical Company Limited , United States Federal Trade Commission , Program Subsidiary , Nimbus Lakshmi , Nimbus Therapeutic , News Global , Completes Acquisition , Rare Genetics , Plasma Derived Therapies , Annual Report ,